Using Ultrasound to Predict the Results of Draining Pleural Effusions
Study Details
Study Description
Brief Summary
Pleural effusion is an extremely common problem with multiple causes; its subsequent investigation with thoracocentesis and treatment with drainage represent two of the most frequently performed diagnostic and therapeutic medical procedures. The role of thoracic ultrasonography in the management of pleural effusion is a modern and rapidly expanding one, having become effectively mandatory and part of the "gold standard" over the past decade due to its diagnostic and patient safety benefits. By contrast, the measurement of intra-pleural pressure using sequential manometry has failed to convincingly demonstrate its clinical value beyond physiological studies despite its availability for over a century. Previous work has shown a potential role for pleural manometry in predicting the presence of un-expandable lung and success of talc pleurodesis but these studies have not been replicated or clinically validated.
We intend to combine the old and new in an observational study comparing findings on thoracic ultrasonography and pleural manometry during thoracocentesis with patient-reported symptoms and the key clinical outcomes of presence of un-expandable lung and success of talc pleurodesis. The investigators hypothesise that the previously described variations in pleural elastance can be correlated with appearances and anatomical changes visualised on thoracic ultrasonography; and in combination can be reliably utilised to predict clinical outcome. The study may allow the proposal of a treatment algorithm that allows patients with pleural effusion to be managed in a more expeditious and efficient manner.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Study-specific interventions will be the monitoring of intrapleural pressure using an electronic pleural manometer (Mirador Biomedical CompassTM Thoracentesis Assist Device) and thoracic ultrasonography. Both of these are considered non-invasive and low-risk to the study participants.
As part of their standard usual clinical care, participants will undergo a diagnostic and/or therapeutic pleural intervention in the form of thoracocentesis or pleural aspiration; intercostal chest drain insertion; and/or talc pleurodesis. All of these procedures are invasive and associated with potential complications that participants will be informed about as part of standard informed consent procedures. These interventions will however be clinically indicated and carried out whether or not an individual chooses to participate in this study. For those individuals who do participate in the study, any complications of these standard clinical care procedures will be recorded as part of the data collection process for the study.
Study Design
Outcome Measures
Primary Outcome Measures
- Diagnosis of unexpandable lung [Up to 3 months]
Clinical and/or radiological diagnosis of unexpandable lung
Secondary Outcome Measures
- Failure of talc pleurodesis [3 months]
Failure of talc pleurodesis (defined as the need for a further repeat pleural procedure for symptom relief within 3 months of attempted pleurodesis).
- Absolute change in patient-reported symptoms [Up to 3 months]
Absolute change in patient-reported symptoms (dyspnoea and chest discomfort) during pleural aspiration or drainage as measured using a visual analogue scale.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
The participant is willing and able to give informed consent for participation in the study.
-
Adult male or female, aged 18 years or above.
-
Diagnosed with a symptomatic pleural effusion requiring either diagnostic and/or therapeutic pleural aspiration or drainage.
-
Expectation by the clinician responsible for assessing the patient that more than 500mL of pleural fluid will be drained on this particular occasion.
Exclusion Criteria:
-
Age less than 18 years
-
Inability to provide informed consent
-
Evidence of significant septation or loculation within the pleural effusion as determined by the clinician responsible for assessing the patient.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Churchill Hospital | Oxford | United Kingdom | OX3 7LE |
Sponsors and Collaborators
- University of Oxford
Investigators
- Study Chair: Najib Rahman, DPhil, MSc, MRCP, University of Oxford & Oxford University Hospitals NHS Trust
- Principal Investigator: John Corcoran, MD, University of Oxford
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PLMAN2013